Compound Physician required

Hexarelin

Potent growth-hormone-releasing peptide — desensitizes with repeated use, unclear regulatory status.

What it does

A potent growth-hormone-releasing peptide that desensitizes with repeated use. Limited human evidence, unclear regulatory status. Tracked, not recommended.

  • growth hormone
  • muscle gain

What the evidence shows

Overall evidence strength: Very low certainty

Who it's for, who should skip

Not available or recommended. Status is gray_zone — not approved, no lawful human-use channel, WADA-prohibited. Tracked pending clearer evidence and a lawful channel.

Measuring it

  • IGF-1 baseline
  • IGF-1 on cycle
  • Fasting glucose baseline
  • Fasting glucose on cycle
  • HbA1c baseline
  • HbA1c quarterly

Access & cost

Legally unsettled. Access, where it exists at all, runs through a physician — not a consumer purchase. See the status note above.

Last reviewed 27 August 2026. Regulatory status verified 27 August 2026.